Cytiva

Cytiva supplies technologies and services that help researchers and biopharma develop and manufacture therapeutics. Its portfolio spans laboratory research through commercial manufacturing, including chromatography, filtration, cell culture media and bioreactors. These tools support monoclonal antibodies, mRNA vaccines, viral vectors and cell and gene therapies.

Part of Danaher, Cytiva reports more than 16,000 employees, operations in 40 countries and over 35 manufacturing sites in its September 2026 company information. Marlborough, Massachusetts is one of its four main regional bases; UK locations include Amersham, Cardiff and Portsmouth. Scientists, engineers and technical specialists work with customers on process development and manufacturing challenges, supporting therapies from discovery through delivery.